A Clinical Study of the Side Effects of L-Asparaginase.
- Author:
Chann Wook WOO
1
;
Jung Hwa LEE
;
Kwang Chul LEE
;
Soon Kyum KIM
Author Information
1. Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
L-asparaginase;
Side effect;
Leukemia;
Lymphoma
- MeSH:
Academic Medical Centers;
Asparaginase;
Child;
Erwinia;
Escherichia coli;
Humans;
Hyperglycemia;
Hypersensitivity;
Korea;
Leukemia;
Lymphoma;
Lymphoma, Non-Hodgkin;
Male;
Medical Records;
Pancreatitis;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
- From:Korean Journal of Pediatric Hematology-Oncology
1999;6(2):298-304
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We evaluated the frequency and clinical characteristics of the side effects of L-asparaginase during treatment of childrens with acute lymphoblastic leukemia (ALL) & Non-Hodgkin lymphoma (NHL). METHODS: Medical records of children who were treated as 37 ALL and 3 NHL in Korea University Medical Center from January 1995 to June 1998 were reviewed. RESULTS: 1) The 40 patients (21 males and 19 females) had a mean age of 6.2+/-3.3 (range, 0.4~12.8). 2) Nine (7 ALL, 2 NHL) of these 40 patients (median: 5.0 years, range: 3.8~11.5 years) had side reactions (5 hypersensitivity, 2 hyperglycemia, 1 pancreatitis, 1 CNS abnormality) to Escherichia coli L-asparaginase. 3) The hypersensitivity reactions to E. coli asparaginase were the most common side effects. Erwinia asparaginase administered to those patients without side reactions. 4) The range of doses of E. coli asparaginase received prior to experiencing any hypersensitivity was 10 to 22 times. 5) Other reactions (hyperglycemia, pancreatitis and CNS abnormality) were developed at early diseases state and completely recovered. CONCLUSION: We found Erwinia asparaginase to be an acceptable substitute for E. coli asparagianse for childrens who had hypersensitivity reactions. In our experience, hypersensitivity reactions are do not detected in inducton therapeutic period. But, We recommend that you should carefully observe your patients during the early induction period.
